$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000112414023000044 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$622.1M	$602.5M	$486.6M
YoY Change	19.26%	23.82%	21.01%
Cost Of Revenue	$157.0M	$156.9M	$134.7M
YoY Change	8.57%	16.45%	22.47%
Gross Profit	$465.1M	$445.6M	$351.9M
YoY Change	23.36%	26.63%	29.59%
Gross Profit Margin	74.76%	73.96%	72.32%
Selling, General & Admin	$414.5M	$404.3M	$402.0M
YoY Change	4.24%	0.57%	-11.44%
% of Gross Profit	89.11%	90.73%	114.23%
Research & Development	$104.1M	$95.42M	$102.2M
YoY Change	-1.87%	-6.68%	-11.52%
% of Gross Profit	22.38%	21.41%	29.06%
Depreciation & Amortization	$50.44M	$26.80M	$22.99M
YoY Change	97.8%	16.56%	12.12%
% of Gross Profit	10.84%	6.01%	6.53%
Operating Expenses	$541.5M	$499.7M	$504.2M
YoY Change	7.51%	-0.9%	-11.86%
Operating Profit	-$76.38M	-$77.09M	-$177.0M
YoY Change	-52.14%	-56.44%	-41.11%
Interest Expense	-$2.990M	$4.597M	-$5.965M
YoY Change	-63.67%	-177.07%	-122.45%
% of Operating Profit
Other Income/Expense, Net	-$2.990M	$4.597M	-$5.965M
YoY Change	-63.67%	-177.07%	-122.45%
Pretax Income	-$79.92M	-$72.49M	-$183.0M
YoY Change	-52.38%	-60.38%	-33.22%
Income Tax	$1.107M	$1.700M	-$2.000M
% Of Pretax Income
Net Earnings	-$81.03M	-$74.15M	-$180.9M
YoY Change	-51.21%	-59.02%	480.6%
Net Earnings / Revenue	-13.02%	-12.31%	-37.19%
Basic Earnings Per Share	-$0.45	-$0.42	-$1.04
Diluted Earnings Per Share	-$0.45	-$0.42	-$1.04
COMMON SHARES
Basic Shares Outstanding	180.4M shares	178.2M shares	174.4M shares
Diluted Shares Outstanding	180.2M shares	178.6M shares	174.4M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$775.7M	$698.6M	$817.0M
YoY Change	6.55%	-14.48%	-40.71%
Cash & Equivalents	$48.38M	$421.4M	$189.8M
Short-Term Investments	$171.3M	$277.3M	$627.2M
Other Short-Term Assets	$89.13M	$85.27M	$79.58M
YoY Change	24.01%	7.16%	52.54%
Inventory	$130.8M	$124.1M	$113.0M
Prepaid Expenses
Receivables	$178.3M	$183.4M	$205.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.174B	$1.091B	$1.215B
YoY Change	6.56%	-10.18%	-31.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$846.2M	$850.9M	$622.6M
YoY Change	-1.11%	36.66%	28.98%
Goodwill	$2.346B	$2.346B	$2.335B
YoY Change	0.01%	0.47%	6.93%
Intangibles	$1.911B	$1.933B	$2.070B
YoY Change	-6.66%	-6.58%	-0.2%
Long-Term Investments
YoY Change
Other Assets	$78.64M	$91.87M	$77.48M
YoY Change	-18.66%	18.57%	36.07%
Total Long-Term Assets	$5.182B	$5.213B	$5.275B
YoY Change	-2.88%	-1.18%	6.38%
TOTAL ASSETS
Total Short-Term Assets	$1.174B	$1.091B	$1.215B
Total Long-Term Assets	$5.182B	$5.213B	$5.275B
Total Assets	$6.356B	$6.304B	$6.491B
YoY Change	-1.27%	-2.87%	-3.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$75.08M	$86.71M	$66.47M
YoY Change	-10.8%	30.45%	91.54%
Accrued Expenses	$329.5M	$241.8M	$365.9M
YoY Change	6.89%	-33.91%	70.87%
Deferred Revenue			$1.300M
YoY Change			-96.73%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$53.80M	$3.200M	$6.400M
YoY Change	1969.23%	-50.0%	-97.96%
Total Short-Term Liabilities	$488.1M	$367.4M	$481.0M
YoY Change	10.09%	-23.62%	-23.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.319B	$2.367B	$2.193B
YoY Change	3.53%	7.92%	16.35%
Other Long-Term Liabilities	$491.6M	$344.4M	$389.1M
YoY Change	35.02%	-11.48%	-6.07%
Total Long-Term Liabilities	$2.811B	$344.4M	$389.1M
YoY Change	671.99%	-11.48%	-6.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$488.1M	$367.4M	$481.0M
Total Long-Term Liabilities	$2.811B	$344.4M	$389.1M
Total Liabilities	$3.299B	$3.247B	$3.232B
YoY Change	2.2%	0.44%	4.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.420B	-$3.339B	-$2.822B
YoY Change	14.44%	18.31%	35.89%
Common Stock	$6.478B	$6.399B	$6.087B
YoY Change	4.37%	5.11%	6.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.057B	$3.058B	$3.258B
YoY Change
Total Liabilities & Shareholders Equity	$6.356B	$6.304B	$6.491B
YoY Change	-1.27%	-2.87%	-3.62%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$81.03M	-$74.15M	-$180.9M
YoY Change	-51.21%	-59.02%	480.6%
Depreciation, Depletion And Amortization	$50.44M	$26.80M	$22.99M
YoY Change	97.8%	16.56%	12.12%
Cash From Operating Activities	$100.4M	-$38.22M	-$173.8M
YoY Change	-264.86%	-78.01%	124.99%
INVESTING ACTIVITIES
Capital Expenditures	$34.72M	$29.36M	$33.62M
YoY Change	-154.83%	-12.68%	160.24%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$101.2M	$0.00	$7.000K
YoY Change	19.07%	-100.0%	-95.04%
Cash From Investing Activities	$66.47M	$82.94M	$45.56M
YoY Change	206.91%	82.04%	-114.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	16.04M	$133.6M	$2.735M
YoY Change	-74.7%	4784.68%	-62.25%
NET CHANGE
Cash From Operating Activities	100.4M	-$38.22M	-$173.8M
Cash From Investing Activities	66.47M	$82.94M	$45.56M
Cash From Financing Activities	16.04M	$133.6M	$2.735M
Net Change In Cash	182.9M	$178.9M	-$125.7M
YoY Change	657.35%	-242.31%	-67.56%
FREE CASH FLOW
Cash From Operating Activities	$100.4M	-$38.22M	-$173.8M
Capital Expenditures	$34.72M	$29.36M	$33.62M
Free Cash Flow	$65.70M	-$67.58M	-$207.4M
YoY Change	2626.27%	-67.41%	130.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35092
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	02-0478229
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5505 Endeavor Lane
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Madison
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	53719
CY2023Q1	dei	City Area Code CityAreaCode	608
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	535-8815
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	EXAS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	180388167	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	421365000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242493000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	277282000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	389564000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183371000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	158043000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	124092000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	118259000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	85274000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73898000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1091384000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	982257000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	684574000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	684756000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	156782000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167003000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2346235000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2346040000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1933481000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1956240000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	91872000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	90577000	usd
CY2023Q1	us-gaap	Assets Assets	6304328000	usd
CY2022Q4	us-gaap	Assets Assets	6226873000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	86713000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74916000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	241844000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	299216000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30014000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28366000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8783000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10249000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	367354000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	412747000	usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2310196000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2186106000	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	50000000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	50000000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	344380000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	352459000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174690000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182399000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3246620000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3183711000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1799000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	179830145	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	179830145	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	177925631	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	177925631	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1780000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6396805000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6311644000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1719000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5236000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3339177000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3265026000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3057708000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3043162000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6304328000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6226873000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	602450000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	156866000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	134705000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	95419000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102248000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	186964000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	232181000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	217295000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	169770000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22928000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24654000	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	69000	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	679541000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	663558000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-77091000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-176987000	usd
CY2023Q1	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	490000	usd
CY2022Q1	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	-1487000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4107000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4478000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4597000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5965000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72494000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-182952000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1657000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2015000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-74151000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.04
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	178574000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	178574000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174417000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	174417000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-74151000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2967000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-4967000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	550000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-237000	usd
CY2023Q1	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-70634000	usd
CY2022Q1	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-186141000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3043162000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	964000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	35077000	usd
CY2023Q1	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	49139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-74151000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3517000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3057708000	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3387636000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4282000	usd
CY2022Q1	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	52441000	usd
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	7000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5204000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3258211000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-74151000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-180937000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	26815000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	22993000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-284000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-321000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3009000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1350000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1261000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1912000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	49139000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	52441000	usd
CY2023Q1	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10324000	usd
CY2022Q1	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	0	usd
CY2023Q1	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	1783000	usd
CY2022Q1	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	1700000	usd
CY2023Q1	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	-54000	usd
CY2022Q1	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	956000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22928000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24654000	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	69000	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8937000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-26680000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	6806000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	7363000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25434000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11020000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5827000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7964000	usd
CY2023Q1	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-5982000	usd
CY2022Q1	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-5177000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4817000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-66048000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	13622000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6619000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1161000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1215000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38215000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-173754000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8589000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	70267000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	121332000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	150630000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29360000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33623000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	442000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1172000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	82941000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	45561000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	964000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4282000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	137976000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5344000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1547000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	133596000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2735000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	550000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-237000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	178872000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-125695000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	242790000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315768000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	421662000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190073000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	10548000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	31491000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6442000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5133000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	421365000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	189776000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	421662000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190073000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q and the 2022 Form 10-K.</span></div>The spread of the coronavirus (“COVID-19”) and the macroeconomic conditions including inflation and fluctuations in foreign currency exchange rates has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company expects these matters to have an impact on operations, however, the ultimate impact presents uncertainty and depends on factors beyond the Company’s knowledge or control, including the duration and severity, as well as third-party actions taken. The Company continues to use the best information available to inform its accounting estimates in light of these uncertainties.
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.</span></div>
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33195000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30098000	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	602450000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	usd
CY2023Q1	us-gaap	Cash Cash	351549000	usd
CY2022Q4	us-gaap	Cash Cash	178168000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	69816000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	64325000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	421365000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242493000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2588000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5149000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	277282000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	389564000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	698647000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	632057000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	346832000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	140000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2462000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	344510000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	454029000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5311000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	448740000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	291400000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	289597000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	55432000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	54913000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	63094000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	322000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	193903000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2140000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	256997000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	2462000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	63433000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	61207000	usd
CY2023Q1	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	60659000	usd
CY2022Q4	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	57052000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	124092000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	118259000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1018737000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	992347000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	334163000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	307591000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	684574000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	684756000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	26800000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	23000000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	79600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	981186000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	297705000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	683481000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2231186000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	297705000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1933481000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	981016000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	274776000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	706240000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2231016000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	274776000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1956240000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	68786000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	91378000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	90331000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	89271000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	89271000	usd
CY2023Q1	exas	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	254444000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	683481000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2335172000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	117000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2346040000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	195000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2346235000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	298000000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	306900000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	306927000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8937000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	297990000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-26700000	usd
CY2023Q1	exas	Financing Receivable Amount Elected To Collateralize FinancingReceivableAmountElectedToCollateralize	50000000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17700000	usd
CY2023Q1	exas	Principal Amount Convertible Note PrincipalAmountConvertibleNote	1000	usd
CY2023Q1	exas	Debt Instrument Repurchase Price Due To Change In Control As Percentage Of Principal Amount DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount	100
CY2023Q1	us-gaap	Share Price SharePrice	67.81
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1378000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1412000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	36000	usd
CY2023Q1	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	10324000	usd
CY2022Q1	exas	Gain On Settlement Of Convertible Notes GainOnSettlementOfConvertibleNotes	0	usd
CY2023Q1	exas	Coupon Interest Expense CouponInterestExpense	3354000	usd
CY2022Q1	exas	Coupon Interest Expense CouponInterestExpense	2567000	usd
CY2023Q1	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	-5561000	usd
CY2022Q1	exas	Interest Expense Income Debt InterestExpenseIncomeDebt	4015000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	2839000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-678000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	3517000	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-5231000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-27000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-5204000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	49100000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52400000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4300000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	9135000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	8097000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	170000	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	211000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	745000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1548000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3833000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4259000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	318000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	878000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M4D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M1D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y25D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0642
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0609
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0667
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0532
CY2023Q1	exas	Operating Lease Right Of Use Asset Modification OperatingLeaseRightOfUseAssetModification	6200000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	156800000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167000000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	204700000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30000000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174700000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	210800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28400000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182400000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9500000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10200000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	10000000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3200000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6800000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10600000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3200000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7400000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	602450000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	486571000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1700000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2000000.0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	19700000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29600000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28300000	usd

Files In Submission

Name	View Source	Status
exas-20230331_lab.xml	Edgar Link	unprocessable
exas-20230331_def.xml	Edgar Link	unprocessable
0001124140-23-000044-index-headers.html	Edgar Link	pending
0001124140-23-000044-index.html	Edgar Link	pending
0001124140-23-000044.txt	Edgar Link	pending
0001124140-23-000044-xbrl.zip	Edgar Link	pending
exas-20230331.htm	Edgar Link	pending
exas-20230331.xsd	Edgar Link	pending
exas-20230331xexx102.htm	Edgar Link	pending
exas-20230331xexx103.htm	Edgar Link	pending
exas-20230331xexx311.htm	Edgar Link	pending
exas-20230331xexx312.htm	Edgar Link	pending
exas-20230331xexx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
exas-20230331_cal.xml	Edgar Link	unprocessable
exas-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
exas-20230331_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2023 Q2 Form 10-Q Financial Statement

#000112414023000044 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2023 Q2 Form 10-Q Financial Statement

#000112414023000044 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas